# Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC

> **NCT03732781** · PHASE1,PHASE2 · COMPLETED · sponsor: **Oncoinvent Solutions AS** · enrollment: 47 (actual)

## Conditions studied

- Peritoneal Carcinoma
- Colorectal Carcinoma

## Interventions

- **DRUG:** Radspherin

## Key facts

- **NCT ID:** NCT03732781
- **Lead sponsor:** Oncoinvent Solutions AS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-27
- **Primary completion:** 2025-05-14
- **Final completion:** 2025-05-14
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03732781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03732781, "Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03732781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*